US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
GE

GETI-B.ST

$234.40
Sharia status
COMPLIANT
Per In-house ratio engine · assessed 2026-08-27
HTR non-permissible income 0.21%
🕌Open research, not a fatwa — verify with your own scholar.
Trade setup SEPARATE FROM SHARIAH
No active setup right now. The technical picture doesn't show a clear edge — check back when the trend or momentum shifts.

Getinge AB (publ) (GETI-B.ST) is currently considered halal (Sharia-compliant), per In-house ratio engine (last assessed 2026-08-27). See the full ratio breakdown and business-activity screen below for the reasoning.

Market & analysts
Price target
$247.60
+5.6% · 10 analysts
Institutional own.
61.7%
of shares
COMPLIANT
Sharia compliance
0.21%
Non-permissible income — HTR, from filings (2025-12-31)
$247.60
Price target (+5.6%) · 10 analysts
61.7%
Institutional ownership

🕌 In-house Compliance Research

Computed from Yahoo Finance fundamentals (Tier-4 provider, no filing available), balance sheet as of 2025-12-31. GETI-B.ST files no SEC reports, so these ratios come from the issuer's own published statements rather than XBRL.

Business activity: cleared (no excluded categories detected)

AAOIFI Pass

RatioValueThresholdResult
Interest-bearing debt 19.10% 30.00% Pass
Interest-bearing investments 5.25% 30.00% Pass
Non-permissible income 0.21% 5.00% Pass

Usmani Pass

RatioValueThresholdResult
Interest-bearing debt 21.88% 33.00% Pass
Interest-bearing investments 6.02% 33.00% Pass
Non-liquid assets 83.75% at least 20.00% Pass
Non-permissible income 0.21% 5.00% Pass

MSCI Pass

RatioValueThresholdResult
Interest-bearing debt 21.88% 33.33% Pass
Cash + interest-bearing securities 6.02% 33.33% Pass
Accounts receivable 16.25% 33.33% Pass
Non-permissible income 0.21% 5.00% Pass

FTSE Pass

RatioValueThresholdResult
Interest-bearing debt 21.88% 33.33% Pass
Cash + interest-bearing securities 6.02% 33.33% Pass
Accounts receivable 16.25% 50.00% Pass
Non-permissible income 0.21% 5.00% Pass

Dow Jones Islamic Market Pass

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 22.59% 33.00% Pass
Cash + interest-bearing securities 6.21% 33.00% Pass
Accounts receivable 10.56% 33.00% Pass
Non-permissible income 0.21% 5.00% Pass

S&P Shariah Pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 22.76% 33.00% Pass
Cash + interest-bearing securities 6.26% 49.00% Pass
Accounts receivable 10.64% 49.00% Pass
Non-permissible income 0.21% 5.00% Pass

MSCI M-Series Pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 22.76% 33.33% Pass
Cash + interest-bearing securities 6.26% 33.33% Pass
Accounts receivable 16.90% 49.00% Pass
Non-permissible income 0.21% 5.00% Pass

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

247.40229.62211.84194.05176.272025-09-112026-03-132026-09-11

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
231.53
S2
233.67
S1
234.73
PIVOT
236.87
R1
237.93
R2
240.07
R3
241.13

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

7-day expected range
233.102 251.698
±3.84% from 242.4, made 2026-09-02 · resolves 2026-09-09
STRONG BUY
from 19 indicators
Not enough resolved predictions yet — 0 of 10 needed before we publish an accuracy figure. 22159 forecast(s) are currently open and will be scored automatically when their horizon expires.

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

Technical Summary

NEUTRAL
19 indicators
OscillatorsNEUTRAL
3 buy · 1 neutral · 3 sell
Moving averagesNEUTRAL
6 buy · 0 neutral · 6 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)40.50NEUTRAL
Stochastic %K (14)0.00BUY
CCI (20)-178.14BUY
Williams %R (14)-100.00BUY
MACD (12,26,9)-2.03SELL
ROC (10)-4.48SELL
Momentum (10)-11.00SELL
EMA (10)239.74SELL
SMA (10)241.34SELL
EMA (20)240.06SELL
SMA (20)242.35SELL
EMA (30)237.89SELL
SMA (30)241.15SELL
EMA (50)231.75BUY
SMA (50)232.59BUY
EMA (100)220.36BUY
SMA (100)212.58BUY
EMA (200)213.16BUY
SMA (200)205.47BUY

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

About Getinge AB (publ)

Healthcare · Medical Devices

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solutions. In addition, the company provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, vascular and cardiothoracic surgery equipment, peripheral stenting, OEM solutions, and beating heart surgery equipment; and operating room equipment, anesthesia, advanced patient monitoring, and operating room integration solutions. Further, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices, and patient flow management; and low temperature sterilization, biocontainment in vaccine production, terminal sterilization, sterile isolation technology, cleaning and sterilization, aseptic transfer, and large-scale cultivation. Additionally, the company provides bioreactor preparation solution, bioprocess development and optimization, labware cleaning and sterilization, biocontainment, and vivarium. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

getinge.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

🕌 In-house Ratio Research — filings.xbrl.org ESEF XBRL

Research only, not the primary verdict above — SEC EDGAR (the source for the main in-house research card, if shown) has no data for this symbol, so this is computed from a real, country-specific filing instead. Business-activity screening isn't part of this check.

AAOIFI Standard 21 (% of market cap) — Unverified
Debt ratio 10.9% (< 30%)
Investments ratio 4.6% (< 30%)
Non permissible income ratio no data
Usmani (% of total assets) — Unverified
Debt ratio 10.9% (< 33%)
Investments ratio 4.6% (< 33%)
Nonliquid assets ratio 95.4% (< 20%)
Non permissible income ratio no data
Net liquid assets -$12.1B (mkt cap $63.8B)

Based on the filing period ending 2024-12-31, figures in SEK.

SMC — Top Down

Not enough price history yet for a smart-money structure read on any timeframe.

Momentum & Volume

Peer Movement

Peer movement computing — it will appear here on its own.

Insider Activity (90d)

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

NEUTRAL   report date 2026-09-01 · Asset managers net 934180 (-19048)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.

Tell us what's working, what's confusing, or what you want to see next — read by a real person, not a form that goes nowhere.